RDB07859 - pGL3-AID R4 del.-05

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions set forth by the DEPOSITOR	In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested. (Nat. Immunol., 11, 148-154 (2010)). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
Additional terms and conditions for distribution	The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
Ordering	Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]

提供案内 (日本国内)

[open/close]

提供条件	利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Nat. Immunol., 11, 148-154 (2010))。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。　学術機関の学術研究に限る。　営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。　利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。
付加的提供条件	本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。
提供依頼	手続きの詳細は、「提供申込みについて[link]」をご覧ください。提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

References and tips

Sequence information

Catalog #	Resource name	Shipping form	Fee (non-profit org.)
RDB07859	pGL3-AID R4 del.-05	DNA solution

original	Tran, T.H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806.

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check

icon as well as clone information before placing your order.

Primer: pGL4-4174F Sequence file: RDB07859_A4Gia.seq
>07859_07859_A4Gi_pGL4-4174F_C01_07.ab1 1 GATAGGGGGC AGACATTTCT CTATCGATAG GTACCCCAGG GCCAAAAGTG AGAAAAACAA 61 AAATCGGGGA ATGGGAAGTG AAGCAATCCA ACAACCACAT TTTCACCCAC ACAAAGCCCT 121 TTTTGGATCC CTTTAAAAAC AACCAGTATC ATATTGAGCA ATCTAGCTGG TGTCCAAAAA 181 TAGTGACCCG AGGAGTCATG TCTGAGTGTG CTGGCTCTGA GACACAGGAA TGCAGCCCCC 241 CCCCCCCCCG AGGCTTTCCA GAGACCGCCA GCCCCTCATG CTGGCCATAA CGAAACCTCA 301 CCTGTGTGTC TCATAGGGAA AGCGAGGTGG TGAACTCCAG ATGTCCAAAA CTCAGCTCAG 361 CCGCAGGCGA CTCGATTTCC AAGTCACAGT ATTTTTGGTT AAAAACAATG TGACCAAGTT 421 GGCTTGTGGT TTTTCAATAG AAGTTAATGA GGGGAAAGAG AAGTTAATGA AGAAAATAAA 481 AGTTGATCAA AACCCTGTAA ACTGCTTTGC CGCTGTACCA GTTCCAAATT TCCCGGGACT 541 GGAAAATGGT TTTTGTAACT AAGTGAGATC TCTTTCCTTC CTTTAGAAGA AGGCAAATGA 601 GAGAATTTGG CTTTCTTACA AATCAAGGGT TTTGTATTTG TTCCTATGGC ATGTGTACGG 661 CATCTGTAAG AGAGGGTGTG GGCGTGCGTG TGCGTGTGCT ACAGCTCGAG TTTAGAGGAA 721 CAGCCTCGAA GGAAGTTGGA CATTAAGCAT GAGCAGAACT GGCCCCCCCC CCCAATCATT 781 TAATCCGTGT GGCTTTGCCC ACCACAGCCC CGCCCATCTT TACTGGACCC AACCCAGGAG 841 GCAGATGTTG GATACCTGGT GGTAGTGATG CTGTCGTGGG GGAGGAGCCC ACAAGAGCAA 901 GCTCAGATTT GAATGCCAGG GGCCAGTGCT CTGTCACACA ACAGCACTGA AGCAGCCTTG 961 CTTGAAGCAA GCTTCCCTTT GGGCCTAAGA CTTTGAGGGA GTCAAGAAAG TCACGCTGGG 1021 AGACCGAATC CATGGGAAGA CGCCCAAAAA CATAAGAAAA GGCCCCGGCG CCATTTCTTA 1081 TTCCCGCTGG AAGAATGGGA AACCGCTGGA GAAGCAACCT GGCCATAGCT ATGAAGAAGA 1141 ATACGCCTTG GTTCCTGGAA CAATTGGCCT TTTTTACCGA GA //
Primer: Luc_R Sequence file: RDB07859_A4Gib.seq
>07869_07869_A4Gi_pGL4-4174F_D06_12.ab1 1 AGCTTGGGGG CCAGGAAAAT TTCTCTATCG ATAGGTACCC CAGGGCCACA AAGTGAGAAA 61 AACAAAAATC GGGGAATGCA GAAGTTGAAG CAATCCAACA ACCACATTTT CACCCACACA 121 AAGCCCTTTT TGGATCCCTT TAAAAACAAC CAGTATCATA TTGAGCAATC TAGCTGGTGT 181 CCAAAAATAG TGACCCGAGG AGTCATGTCT GAGTGTGCTG GCTCTGAGAC ACAGGAATGC 241 AGCCCCCCCC CCCCCCGAGG CTTTCCAGAG ACCGCCAGCC CCTCATGCTG GCCATAACGA 301 AACCTCACCT GTGTGTCTCA TAGGGAAAGC GAGGTGGTGA ACTCCAGATG TCCAAAACTC 361 AGCTCAGCCG CAGGCGACTC GATTTCCAAG TCACAGTATT TTTGGTTAAA AACAATGTGA 421 CCAAGTTGGC TTGTGGTTTT TCAATAGAAG TTAATGAGGG GAAAGAGAAG TTAATGAAGA 481 AAATAAAAGT TGATCAAAAC CCTGTAAACT GCTTTGCCGC TGTACCAGTT CCAAATTTCC 541 CGGGACTGGA AAATGGTTTT TGTAACTAAG TGAGATCTCT TTCCTTCCTT TAGAAGAAGG 601 CAAATGAGAG AATTTGGCTT TCTTACAAAT CAAGGGTTTT GTATTTGTTC CTATGGCATG 661 TGTACGGCAT CTGTAAGAGA GGGTGTGGGC GTGCGTGTGC GTGTGCTACA GCTCGAGTTT 721 AGAGGAACAG CCTCGAAGGA AGTTGGACAT TAAGCATGAG CAGAACTGGC CCCCCCCCCC 781 AATCATTTAA TCCGTGTGGC TTTGCCCACC ACAGCCCCGC CCATCTTTAC TGGACCCAAC 841 CCAGGAGGCA GATGTTGGAT ACCTGGTGGT AGTGATGCTG TCGTGGGGGG AGGAGCCCAC 901 AAGAGCAAGC TCAGATTTGA ATGCCAGGGG CCAGTGCTCT GTCACACAAC AGCACTGAAG 961 CAGCCTTGCT TGAAGCAAGC TTTCCTTTGG CCTAAGACTT TGAAGGAGTC AAGAAAGTCA 1021 ACGCTGGAGA CCGATCCATG GAGAACGTCA AAACATAAAG AAAGGCCGCG CCCATTCTAT 1081 CGGCTTGAAG ATGAACCGCT GGAAAGCAAC TGCATAGGCT ATGAGAGAAT ACGCCCTGGT 1141 TTCCGTGGAA CCAAT //

pGL3-AID R4 del.-05

Distribution information

References and tips

Sequence information

References